Comorbidity and multimorbidity in patients with schizophrenia and bipolar disorder: Similarities and differencies

Psychiatria Danubina

Volumn 24, Issue 1, 2012, Pages 80-85

  Oreški, Ivan ^a   Jakovljević, Miro ^a   Aukst Margetić, Branka ^a   Orlić, Željka Crnčević ^b   Vuksan Ćusa, Bjanka ^a  

^a KBC Zagreb   (Croatia)

^b KBC RIJEKA   (Croatia)

Author keywords

Bipolar disorder; Comparative comorbidity; Schizophrenia

Indexed keywords

ADULT; ARTICLE; BIPOLAR DISORDER; CARDIOVASCULAR DISEASE; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOCRINE DISEASE; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; ICD-10; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MENTAL DISEASE; METABOLIC DISORDER; NEUROLOGIC DISEASE; PREVALENCE; PSYCHOSOMATIC DISORDER; RETROSPECTIVE STUDY; SCHIZOPHRENIA;

ADULT; BIPOLAR DISORDER; CHRONIC DISEASE; COMORBIDITY; CROATIA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOPHYSIOLOGIC DISORDERS; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84860827880     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Aukst Margetić B, Jakovljević M, Brataljenović T & ŠumićM: Personality and schizophrenia: Psychobiological model and its relationship with comorbidity. Psychiatria Danubina 2009; 21:356-360.
2. Beyer J, Kuchibhatla M, Gersing K & Krishnan KR: Medical comorbidity in a bipolar outpatient clinical population. Neuropsychopharmacology 2005; 30:401-404. (Pubitemid 40129491)
3. Buckley PF, Miller BJ, Lehrer DS & Castle DJ: Psychiatric comorbidity and schizophrenia. Schizophrenia Bulletin 2009; 35:383-402.
4. Coclami T & Cross M: Psychiatric co-morbidity with type I and type II diabetes mellitus. EMHJ 2011; 17:777-783
5. De Hert M, Dekker JM, Wood D, Kahl KG, Holt RIG &Moeller HJ: Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the study of Diabetes (EASD) and the European Society of Cardiology (ESC). European Psychiatry 2009; 24: 412-424.
6. Harris AE: Physical diseasse and schizophrenia, Schizophrenia Bulletin 1988; 14:85-96.
7. Hayashi T & Su TP: Cholesterol at the endoplasmatic reticulum: Roles of the sigma-1 receptor chaperone and implications thereof in human diseases. Subcell Biochem 2010; 51:381-398. doi:10.1007/978-90-481-8622-8-13.
8. Hoang U, Stewart R & Goldacre MJ: Mortality after hospital discharge for people with schizophrenia or bipolar disorder: retrospective study of linked English hospital episode statistics, 1999-2006. BMJ 2011; 343:d5422 doi: 10.1136/bmj.d5422
9. Iacovides A & Siamouli M: Comorbid mental and somatic disorders: an epidemiological perspective. Current Opinion in Psychiatry 2008; 21:417-421. (Pubitemid 351787147)
10. Jakovljević M, Mueck-Šeler D, Jelovac N, Ercegović N, Plavšić V, Ćulig J, Koršić M & Montani M: Gastroduodenal ulcer disease in schizophrenia and major depression: platelet serotonin and plasma cortisol investigation. Psychiatria Danubina 1993; 5:277-294
11. Jakovljević M, Crnčević Z, Ljubičić Dj, Babić D, Topić R & Šarić M: Mental disorders and metabolic syndrome: A fatamorgana or warning reality? Psychiatria Danubina 2007; 19:76-86.
12. Jakovljević M: Psychopharmacotherapy and comorbidity: Conceptual and epistemiological issues, dilemmas and controversies. Psychiatria Danubina 2009; 21:333-340.
13. Jakovljević M, Reiner Ž, Miličić D & Crnčević Ž: Comorbidity, multimorbidity and personalized psychosomatic medicine: Epigenetics rolling on the horizon. Psychiatria Danubina 2010; 22:184-189.
14. Jakovljević M & Crnčević Ž: Comorbidity as an epistemiological challenge to modern psychiatry. Dialogues in Philosophy, Mental and Neuro Sciences 2012; in press.
15. Jukić V, Petrović Z, Brečić P, Križaj A, Savić A, Bačeković A, Bilić P, Sušac A, Mandić A & Pražen I: Psychopharmacology in the prevention of somatic comorbid diseases in mentally ill patients. Psychiatria Danubina 2009; 21:350-355.
16. Kemp DE, Gao K, Chan P, Ganocy SJ, Findling RL &Calabrese JR: Medical comorbidy in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment. Bipolar Disord. 2010; 12:404-413.
17. Kozumplik O, Uzun S & Jakovljević M: Psychotic disorders and comorbidity: Somatic illness vs. side effect. Psychiatria Danubina 2009; 21:361-367.
18. Kilbourne AM, Brar JS, Drayer RA, Hu X & Post EP: Cardiovascular disease and metabolic risk factors in male patients with schizophrenia, schizoaffective disorder and bipolar disorder. Psychosomatics 2007; 48:412-417. (Pubitemid 47330294)
19. Krishnan KRR: Psychiatric and medical comorbidity in bipolar disorders. Psychosomatic Medicine 2005; 67:1-8.
20. Laursen TM, Munk-Olsen T & Gasse C: Chronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolar affective disorder. PLoS One 2011:6:e24597. doi:10.1371/journal.pone.0024597
21. Moreira CLRL, Brietzke E & Lafer B: General medical comorbidities in Brazilian outpatients with bipolar disorder type I. Rev Psiq Clin. 2011; 38:227-230.
22. Nasrallah HA, Meyer JM, Goff DC, McEvoy JP, Davis SM, Stroup TS & Lieberman JY: Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline. Schizophrenia Research 2006; 86:15-22. (Pubitemid 44234064)
23. Oud MJT & de Jong BM: Somatic diseases in patients with schizophrenia in general practice: their prevalence and health care. BMC Family Practice 2009; 10:32 doi:10.1186/1471-2296/10/32
24. Vila-Rodriguez F, Honer WG, Innis SM, Wellington CL &Beasley CL: ApoE and cholesterol in schizophrenia and bipolar disorder: comparison of grey and white matter and relation with APOE genotype. J Psychiatry Neurosci 2011; 36:47-55.
25. Vuksan-Ćusa B, Marčinko D, Šagud M & Jakovljević M: The comorbidity of bipolar disorder and cardiovascular diseases from pharmacotherapy perspective. Psychiatria Danubina 2009; 21:382-385.